Provided by Tiger Trade Technology Pte. Ltd.

Mural Oncology

2.04
0.0000
Volume:- -
Turnover:259.92K
Market Cap:35.38M
PE:-0.29
High:2.04
Open:2.04
Low:2.04
Close:2.04
52wk High:4.74
52wk Low:0.9500
Shares:17.34M
Float Shares:14.04M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.9259
EPS(LYR):-7.5799
ROE:-103.87%
ROA:-49.05%
PB:0.64
PE(LYR):-0.27

Loading ...

Company Profile

Company Name:
Mural Oncology
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Mural Oncology Plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops engineered interleukin-18 and tumor-targeted interleukin-12 programs. The company was incorporated in 2017 and is based in Dublin, Ireland. As of November 15, 2023, Mural Oncology Plc operates as a former subsidiary of Alkermes plc.